Cipla
Дженерики, респираторные средства и активные фармацевтические ингредиенты.
Cipla производит дженерики, респираторные средства и активные фармацевтические ингредиенты на своих предприятиях в Мумбаи. Компания поставляет продукцию розничным, промышленным, медицинским, общественным и экспортным клиентам на перечисленных основных рынках.
- Type
- brand seeking distribution
- Location
- Mumbai, India
- Founded
- 1935
- Website
- cipla.com
- Categories
- Медицинские товары и расходники
- Markets
- Индия, Соединенные Штаты, Южно-Африканская Республика, ОАЭ
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- domain-registered (green), checked 2026-08-08 Domain registry record
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- customer-reviews (amber), checked 2026-08-08 MouthShut
- export-registered (green), checked 2026-08-21 Pharmexcil member directory (Pharmaceuticals Export Promotion Council of India, Ministry of Commerce)
- lei-active (green), checked 2026-08-30 GLEIF global LEI register (golden copy)
- registry-activity (green), checked 2026-08-21 Pharmexcil member directory (Pharmaceuticals Export Promotion Council of India, Ministry of Commerce)
Claimed certifications
- Good Manufacturing Practice
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)